Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

We aimed to investigate the associations of neonatal 25‐hydroxyvitamin D (25(OH)D) and vitamin D‐binding protein (DBP) and their corresponding genetic predictors with asthma risk.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Secondary analysis.

Secondary analysis

Analyses existing study data; this paper is not automatically another independent trial.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We conducted two secondary analyses: First, we examined the association of PGSs for asthma, 25(OH)D, and DBP and asthma risk.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Neonatal vitamin D status and asthma risk after age 5 years: A Danish population‐based cohort study

Secondary analysis · Pediatric Allergy and Immunology · 2026

Original publication title

Neonatal vitamin D status and asthma risk after age 5 years: A Danish population‐based cohort study

Xiaoqin Liu; Zhihong Zhu; Bo Chawes; Klaus Bønnelykke; Henriette Thisted Horsdal; Esben Agerbo; Sanne Grundvad Boelt; Nis Borbye‐Lorenzen; Lars Melgaard; Carsten Bøcker Pedersen; John J. McGrath

© 2026 The Author(s). Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our study suggests that neonatal vitamin D status is not associated with asthma risk. Similarly, genetic liability related to vitamin D status, as reflected in PGSs for 25(OH)D and DBP, is not associated with an increased risk of asthma.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Vitamin D may play a role in early lung development, yet epidemiologic evidence on its association with later asthma risk is mixed. We aimed to investigate the associations of neonatal 25‐hydroxyvitamin D (25(OH)D) and vitamin D‐binding protein (DBP) and their corresponding genetic predictors with asthma risk.

Source: Background

Abstract: What methods does the paper describe?

We conducted a population‐based cohort study of a random sample of individuals born in Denmark during 1991 to 2005 from the iPSYCH2012 study. Neonatal concentrations of 25(OH)D and DBP were measured via dried blood spots, and asthma cases were identified through diagnoses or asthma prescriptions after age 5 years. Cox regression was used to estimate hazard ratios (HRs) for asthma in relation to 25(OH)D, DBP, and polygenic scores (PGSs) for these traits and asthma to assess genetic liability to vitamin D status and asthma.

Source: Methods

Abstract: Results

Of 14,005 individuals, 2308 (16.5%) developed asthma over a maximum follow‐up of 25 years. We found no association between neonatal 25(OH)D (HR = 1.04, 95% CI: 0.99 to 1.09 per SD increase) or DBP (HR = 1.01, 95% CI: 0.97 to 1.05) and asthma risk. Analyses using tertiles to assess potential non‐linear associations yielded similar null results. A higher asthma PGS was associated with increased asthma risk (HR = 1.42, 95% CI: 1.36 to 1.47 per SD increase), whereas PGSs for 25(OH)D (HR = 1.00, 95% CI: 0.96 to 1.05) and DBP (HR = 0.99, 95% CI: 0.95 to 1.04) were not.

Source: Results

Abstract: Conclusions

Our study suggests that neonatal vitamin D status is not associated with asthma risk. Similarly, genetic liability related to vitamin D status, as reflected in PGSs for 25(OH)D and DBP, is not associated with an increased risk of asthma.

Source: Conclusions
Authors’ abstract

Abstract

Background

Vitamin D may play a role in early lung development, yet epidemiologic evidence on its association with later asthma risk is mixed. We aimed to investigate the associations of neonatal 25‐hydroxyvitamin D (25(OH)D) and vitamin D‐binding protein (DBP) and their corresponding genetic predictors with asthma risk.

Methods

We conducted a population‐based cohort study of a random sample of individuals born in Denmark during 1991 to 2005 from the iPSYCH2012 study. Neonatal concentrations of 25(OH)D and DBP were measured via dried blood spots, and asthma cases were identified through diagnoses or asthma prescriptions after age 5 years. Cox regression was used to estimate hazard ratios (HRs) for asthma in relation to 25(OH)D, DBP, and polygenic scores (PGSs) for these traits and asthma to assess genetic liability to vitamin D status and asthma.

Results

Of 14,005 individuals, 2308 (16.5%) developed asthma over a maximum follow‐up of 25 years. We found no association between neonatal 25(OH)D (HR = 1.04, 95% CI: 0.99 to 1.09 per SD increase) or DBP (HR = 1.01, 95% CI: 0.97 to 1.05) and asthma risk. Analyses using tertiles to assess potential non‐linear associations yielded similar null results. A higher asthma PGS was associated with increased asthma risk (HR = 1.42, 95% CI: 1.36 to 1.47 per SD increase), whereas PGSs for 25(OH)D (HR = 1.00, 95% CI: 0.96 to 1.05) and DBP (HR = 0.99, 95% CI: 0.95 to 1.04) were not.

Conclusions

Our study suggests that neonatal vitamin D status is not associated with asthma risk. Similarly, genetic liability related to vitamin D status, as reflected in PGSs for 25(OH)D and DBP, is not associated with an increased risk of asthma.

Publication and source details

Original title: Neonatal vitamin D status and asthma risk after age 5 years: A Danish population‐based cohort study

Xiaoqin Liu; Zhihong Zhu; Bo Chawes; Klaus Bønnelykke; Henriette Thisted Horsdal; Esben Agerbo; Sanne Grundvad Boelt; Nis Borbye‐Lorenzen; Lars Melgaard; Carsten Bøcker Pedersen; John J. McGrath

Pediatric Allergy and Immunology · 2026

* Correspondence
Xiaoqin Liu, NCRR‐the National Centre for Register‐Based Research, Department of Public Health, Aarhus University, Bartholins Allé 2, 8000 Aarhus C, Denmark.
Email: lxq.ncrr@au.dk
© 2026 The Author(s). Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Danmarks Grundforskningsfond10.13039/501100001732 Lundbeck Foundation10.13039/501100003554

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:13:52.639673+00:00

DOI: 10.1111/pai.70299 · PMC12929039